Project
Single arm open label phase II pilot study of carboplatin in patients with metastatic castration-resistant prostate cancer (CRPC) and PTEN-loss and/or DNA repair defects. PRO-PLAT
Automatically Closed ยท 2016 until 2019
Omlin Aurelius
No results found.